share_log

4: Statement of changes in beneficial ownership of securities-Officer MILLER TYRONE

4: Statement of changes in beneficial ownership of securities-Officer MILLER TYRONE

4:持股变动声明-高管 MILLER TYRONE
美股sec公告 ·  05/21 20:25
Moomoo AI 已提取核心信息
Tyrone Miller, CFO of 60 Degrees Pharmaceuticals, completed the purchase of 75,000 shares of the company's common stock in a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Miller's direct holdings in the company increased to 176,928 shares. The transactions are reported as grants, awards, or other acquisitions, reflecting a positive investment by the CFO in the company's stock.
Tyrone Miller, CFO of 60 Degrees Pharmaceuticals, completed the purchase of 75,000 shares of the company's common stock in a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Miller's direct holdings in the company increased to 176,928 shares. The transactions are reported as grants, awards, or other acquisitions, reflecting a positive investment by the CFO in the company's stock.
60 Degrees Pharmicals首席财务官泰隆·米勒通过一系列交易完成了对该公司7.5万股普通股的收购。这些收购发生在2024年4月12日至2024年5月16日之间,价格从每股0.223美元到0.2668美元不等。这些交易之后,米勒在该公司的直接持股量增加到176,928股。这些交易以补助金、奖励或其他收购的形式报告,反映了首席财务官对公司股票的积极投资。
60 Degrees Pharmicals首席财务官泰隆·米勒通过一系列交易完成了对该公司7.5万股普通股的收购。这些收购发生在2024年4月12日至2024年5月16日之间,价格从每股0.223美元到0.2668美元不等。这些交易之后,米勒在该公司的直接持股量增加到176,928股。这些交易以补助金、奖励或其他收购的形式报告,反映了首席财务官对公司股票的积极投资。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息